Disparities in Thoracic Oncology Patients
Cancers · 28.02.2026 · 18 (5) · 793
DOI: 10.3390/cancers18050793 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.02.2026. Verfasst von Mohammad W Awlad Mohammad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Quds University, East Jerusalem 20002, Palestine. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Lung cancer is one of the major causes of mortality worldwide despite breakthroughs in screening, diagnosis, and treatment. These advances have not been evenly spread, and discrepancies between populations remain concerning. This article examines lung cancer discrepancies in epidemiology, risk factors, screening, diagnosis, treatment access and quality, and survival outcomes, and identifies the main causes.
Methods
An extensive narrative evaluation of peer-reviewed literature, national cancer surveillance reports, and large population-based research was searched. The evidence on lung cancer disparities by race, ethnicity, socioeconomic status, sex, geography, and healthcare access was synthesized. Disparities in prevention, early identification, treatment, and outcomes were organized into this paper.
Results
Lung cancer incidence, stage, treatment, and survival showed persistent differences. Racial and ethnic minority groups, people on low-incomes, uninsured people, and rural or resource-limited people had higher disease burden and worse outcomes. Access to low-dose computed tomography screening, rapid diagnostic follow-up, surgical resection, molecular testing, targeted medicines, immunotherapy, palliative care, and clinical trials was unequal. When guidelines are followed, survival outcomes are similar across races and ethnicities.
Conclusions
Lung cancer disparities are mostly caused by structural, social, and healthcare system factors, not biology. Coordinated measures to provide equitable screening, prompt and high-quality treatment, research inclusion, and culturally sensitive and policy-driven actions are needed to enhance lung cancer outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Al-Quds University, East Jerusalem 20002, Palestine.
- Department of General Surgery, Faculty of Medicine, Al-Quds University, East Jerusalem 2002, Palestine.
- Department of Thoracic Surgery, The Edith Wolfson Medical Center, Holon 58100, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
ORCID-Profile: Mohammad W Awlad Mohammad, Rita Yacoub
Zitieren
APA
Awlad Mohammad, M. W., Abu Hashhash, K., Yacoub, R., & Abu Akar, F. (2026). Disparities in Thoracic Oncology Patients. Cancers, 18(5), 793. https://doi.org/10.3390/cancers18050793
Vancouver
Awlad Mohammad MW, Abu Hashhash K, Yacoub R, Abu Akar F. Disparities in Thoracic Oncology Patients. Cancers. 2026;18(5):793. doi:10.3390/cancers18050793
BibTeX
@article{AwladMohammad2026,
author = {Awlad Mohammad, Mohammad W and Abu Hashhash, Kinda and Yacoub, Rita and Abu Akar, Firas},
title = {Disparities in Thoracic Oncology Patients},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {793},
doi = {10.3390/cancers18050793}
}
EUVIMED